The largest ever clinical trial of T cell therapy (a type of cell-based immunotherapy) for solid tumours has been completed. Led by a Singapore clinician-investigator, the global, international, ...

The largest ever clinical trial of T cell therapy for solid tumours has ended, heralding a new era for precision T cell ...

Virologist Beata Halassy treated her own cancer and exclaimed that self-treatment was a very positive experience for her.

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

NKTR-255 in combination with durvalumab following chemoradiation was well-tolerated in patients with non–small cell lung ...

A2 Bio shares clinical study progress and the increased diversity of participants in the BASECAMP-1 prescreening study during the SITC annual meeting.

Researchers at Tel Aviv University (TAU) can add to that list their important discovery of a cancer mechanism that has been ...

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

Initial trials using CAR T cells in patients with autoimmune disorders have shown encouraging results, fostering optimism that these therapies could provide long-sought solutions for chronic immune ...

The discovery offers insight into why shift workers experience metabolic disruption, which could lead to new therapies for ...

The heart tissue showed upregulation of molecular pathways that help recruit and retain immune cells involved in inflammation. Patients with active disease also had greater abundance of clusters of ...

The immune system is a major target for cancer treatments. Immune checkpoint inhibitors and CAR-T cell therapy can dramatically improve outcomes for many cancers. But for about 70% of patients, these ...